Occupational insecticide exposure and risk of non-Hodgkin lymphoma: A pooled case-control study from the InterLymph Consortium.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 11 2021
Historique:
revised: 07 06 2021
received: 12 02 2021
accepted: 18 06 2021
pubmed: 17 7 2021
medline: 23 11 2021
entrez: 16 7 2021
Statut: ppublish

Résumé

Evidence for the human health effects of pesticides is needed to inform risk assessment. We studied the relationship between occupational insecticide use and risk of non-Hodgkin lymphoma (NHL) by pooling data from nine case-control studies participating in the InterLymph Consortium, including 7909 cases and 8644 controls from North America, the European Union and Australia. Insecticide use was coded using self-report or expert assessment, for insecticide groups (eg, organophosphates, pyrethroids) and active ingredients (eg, malathion, permethrin). Associations with insecticides were estimated using logistic regression to produce odds ratios (ORs) and 95% confidence intervals (CI) for all NHL and NHL subtypes, with adjustment for study site, demographic factors and use of other pesticides. Occupational insecticide use, overall, was not associated with risk of NHL. Use of organophosphate insecticides was associated with increased risk of all NHL and the subtype follicular lymphoma, and an association was found with diazinon, in particular (ever use: OR = 2.05, 95%CI: 1.24-3.37). The carbamate insecticide, carbaryl, was associated with risk of all NHL, and the strongest associations were found with T-cell NHL for ever-use (OR = 2.44, 95%CI: 1.13-5.28) and longer duration (>8 years vs never: OR = 2.90, 95%CI: 1.02-8.25). There was no association of NHL with other broad groups of insecticides, including organochlorines and pyrethroids, and some inverse associations were estimated in relation to historical DDT use. Our findings contribute to the totality of evidence available to help inform risk decisions by public health and regulatory agencies of importance given continued, widespread use of organophosphate and carbamate insecticides.

Identifiants

pubmed: 34270795
doi: 10.1002/ijc.33740
pmc: PMC10560384
mid: NIHMS1933525
doi:

Substances chimiques

Insecticides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1768-1786

Subventions

Organisme : NCI NIH HHS
ID : P50 CA097274
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA092153
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA199515
Pays : United States

Informations de copyright

© 2021 UICC.

Références

Lancet Oncol. 2015 May;16(5):490-1
pubmed: 25801782
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Cancer Causes Control. 2014 Sep;25(9):1233-7
pubmed: 24981100
BMC Med Res Methodol. 2019 Jul 1;19(1):135
pubmed: 31262266
Ann Oncol. 1998;9 Suppl 5:S25-30
pubmed: 9926234
Occup Environ Med. 2009 May;66(5):291-8
pubmed: 19017688
Cancer. 1982 May 15;49(10):2112-35
pubmed: 6896167
Int J Mol Epidemiol Genet. 2011;2(2):95-113
pubmed: 21686124
Am J Epidemiol. 2005 Nov 1;162(9):849-57
pubmed: 16177143
Am J Ind Med. 2003 Dec;44(6):627-36
pubmed: 14635239
Am J Epidemiol. 2004 Jan 15;159(2):148-54
pubmed: 14718216
Occup Environ Med. 2013 Feb;70(2):91-8
pubmed: 23117219
Int J Epidemiol. 1993;22 Suppl 2:S42-5
pubmed: 8132391
Environ Int. 2019 Jun;127:199-205
pubmed: 30928843
Environ Health Perspect. 2016 Apr;124(4):396-405
pubmed: 26340796
Int J Cancer. 2020 Dec 15;147(12):3370-3383
pubmed: 32574374
Blood. 2010 Nov 18;116(20):e90-8
pubmed: 20699439
Cancer Causes Control. 2019 Apr;30(4):311-322
pubmed: 30805813
PLoS One. 2014 Oct 22;9(10):e109332
pubmed: 25337994
Occup Environ Med. 2009 Jan;66(1):68-70
pubmed: 18805876
Occup Environ Med. 2020 Oct;77(10):659-665
pubmed: 32647039
Cancer Res. 1992 Oct 1;52(19 Suppl):5510s-5515s
pubmed: 1394165
IARC Monogr Eval Carcinog Risks Hum. 1991;53:5-586
pubmed: 1688189
J Occup Environ Med. 2018 Oct;60(10):911-916
pubmed: 30289833
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14
pubmed: 25174022
Lancet Oncol. 2015 Aug;16(8):891-2
pubmed: 26111929
Cancer. 2020 Mar 1;126(5):1077-1089
pubmed: 31909824
Int J Epidemiol. 2019 Oct 1;48(5):1519-1535
pubmed: 30880337

Auteurs

Anneclaire J De Roos (AJ)

Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.

Leah H Schinasi (LH)

Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.

Lucia Miligi (L)

Environmental and Occupational Epidemiology Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

James R Cerhan (JR)

Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

Parveen Bhatti (P)

Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.
Occupational and Environmental Health, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Andrea 't Mannetje (A)

Center for Public Health Research, Massey University-Wellington Campus, Wellington, New Zealand.

Dalsu Baris (D)

Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.

Yolanda Benavente (Y)

Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO)/Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Geza Benke (G)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Jacqueline Clavel (J)

Epidemiology of Childhood and Adolescent Cancers Group, Inserm, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
Université Paris Descartes, Paris, France.

Delphine Casabonne (D)

Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO)/Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Lin Fritschi (L)

Curtin University, Perth, Australia.

Jonathan N Hofmann (JN)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Betthesda, Maryland, USA.

Tran Huynh (T)

Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.

Alain Monnereau (A)

Epidemiology of Childhood and Adolescent Cancers Group, Inserm, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, University of Bordeaux, Inserm, Bordeaux, France.

Sara Piro (S)

Environmental and Occupational Epidemiology Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Susan L Slager (SL)

Division of Computational Biology and Hematology, Department of Quantitative Health Sciences and Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Claire M Vajdic (CM)

Centre for Big Data Research in Health, University of New South Wales, New South Wales, Australia.

Sophia S Wang (SS)

Division of Health Analytics, Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

Yawei Zhang (Y)

National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Leslie Bernstein (L)

Division of Biomarkers of Early Detection and Prevention, Beckman Research Institute of City of Hope, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

Pierluigi Cocco (P)

Division of Population Health, Centre for Occupational and Environmental Health, University of Manchester, Manchester, UK.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH